Phase II Trial Assessing Granulocyte-macrophage—Colony Stimulating Factor, Ketoconazole Plus Mitoxantrone in Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Treatments

By Amato Robert J.   Saxena Somyata   Stepankiw Mika  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 177-182

Informa Healthcare

Access to resources Recommend Favorite

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients

By Ibrahim Ezzeldin   Al-Mulhim Fatma  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 47-51

Humana Press, Inc

Access to resources Recommend Favorite

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

By Oshika Y.   Nakamura M.   Abe Y.   Fukuchi Y.   Yoshimura M.   Itoh M.   Ohnishi Y.   Tokunaga T.   Fukushima Y.   Hatanaka H.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1958-1961

Elsevier

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-stimulating Factor Therapy in Patients With Chemotherapy-induced Aplasia and Clostridium difficile Enterocolitis

By Geiger R.   Fussenegger J.   Allerberger F.   Maurer K.   Fink F.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2416-2417

Elsevier

Access to resources Recommend Favorite